RegAsk, a Singapore-based healthcare regtech startup, secured a seed funding of undisclosed amount.
TKS 1, a venture capital collaboration between SPRIM and Tikehau Capital (TKO.FP), an alternative asset management and investment company, made the investment.
The company intends to use the funds to carry out its growth strategy, and its product development plan.
Led by Caroline Shleifer, president, RegAsk is a company that allows healthcare firms to manage regulatory compliance in global markets. It uses artificial intelligence to answer regulatory questions, including inquiries about path-to-market, path-to-claim, product registration and regulatory strategy.
The company offers a full scope of regulatory services including compliance, path-to-market, path-to-claim, product registration and regulatory strategy for the food, dietary supplement, cosmetic, personal care and medical device industries.